-
Innovation Ranking
NewInnovation Ranking – Coherent Inc
Coherent Corp Coherent Inc (Coherent) is a provider of industrial and fiber laser solutions. It manufactures photonics and offers lasers, and laser-based technologies and system solutions for a range of scientific, commercial and industrial applications. The company’s product portfolio includes lasers, laser machines and systems, beam delivery components, and optical fibers. Its products find application in the microelectronics, scientific and government programs, material processing, and OEM components and instrumentation markets. Coherent has manufacturing facilities in the US, Germany, Finland, Scotland,...
-
Product Insights
Optical Coherence Tomography (OCT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Optical Coherence Tomography (OCT) Pipeline Market Report Overview Optical Coherence Tomography (OCT) equipment allows for the imaging and measurement of retinal thickness. The Optical Coherence Tomography pipeline market research report provides comprehensive information about the OCT pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories · The US · China · Europe · Global · Japan Key Regulatory Paths · 510(k) · NMPA...
-
Company Insights
Innovation and Patenting activity of Coherent Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Coherent Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Company Insights
Innovation and Patenting activity of Coherent Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Coherent Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewLikelihood of Approval Analysis for Choroidal Disease
Overview How likely is it that the drugs in Choroidal Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Choroidal Disease Overview Choroidal dystrophy is an eye disorder that involves a...
-
Product Insights
NewLikelihood of Approval Analysis for Intermediate Uveitis
Overview How likely is it that the drugs in Intermediate Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Intermediate Uveitis Overview Intermediate uveitis is a type of uveitis, which is...
-
Product Insights
NewLikelihood of Approval Analysis for Retinal Vascular Occlusion
Overview How likely is it that the drugs in Retinal Vascular Occlusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Vascular Occlusion Overview Retinal vascular occlusion is a condition that...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Uveal Melanoma
Overview How likely is it that the drugs in Metastatic Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Uveal Melanoma Overview Metastatic uveal melanoma is a rare and...
-
Track & Monitor
Robotics in Oil & Gas: Automated Drilling Tools
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the oil & gas industry’s Automated Drilling Tools segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or...
-
Track & Monitor
Immuno-oncology in Pharmaceuticals: Antibody drug conjugates(ADC) cancer therapy
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s Antibody drug conjugates(ADC) cancer therapy segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or...